TGFB1 and Parkinson disease: Specifically, microglia-derived TGF-β2 is beneficial in PD pathology; addition of exogenous TGF-β2 peptide in TGF-β-depleted microglial conditioned media has been shown to counteract 6-OHDA-induced neurotoxicity of cerebellar granule neurons [351].